Prescription drug · ANDA
Lisinopril NDC 68180-515
Lisinopril 20 mg/1 · Tablet · Oral · Lupin Pharmaceuticals, Inc.
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Lisinopril
- Generic name (nonproprietary)
- lisinopril
- Active ingredients
- Lisinopril — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Lupin Pharmaceuticals, Inc.NDC labeler code 68180
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077321
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)
- Identifiers
- Product ID 68180-515_6723a96d-02f8-40c2-95ec-89a7053a7117SPL ID 6723a96d-02f8-40c2-95ec-89a7053a7117SPL set ID 7d6c31e2-b5a4-4279-8013-a8dad37ea73bRxCUI 197884, 205326, 311353, 311354, 314076, 314077UNII E7199S1YWRUPC 0368180513018, 0368180512028, 0368180513032
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Lisinopril tablet USP is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older ( 1.1 ) Adjunct therapy for heart failure ( 1.2 ) Treatment of Acute Myocardial Infarction ( 1.3 ) 1.1 Hypertension Lisinopril tablet USP is indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic class…
Excerpt only. Read the full label for complete information.
About NDC 68180-515
- What is NDC 68180-515?
- 68180-515 is the product NDC for Lisinopril, Lisinopril 20 mg/1 tablet, listed with the FDA by Lupin Pharmaceuticals, Inc..
- What drug is associated with this NDC?
- Lisinopril.
- What is the active ingredient?
- Lisinopril.
- Who is the labeler?
- Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lisinopril?
- 266 other product NDCs are listed under this name. See all Lisinopril NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lisinopril products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Coupler LLC | 67046-2097 | 67046-2097-03 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-047 | 87441-0047-01 |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-048 | 87441-0048-01 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-049 | 87441-0049-01 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | Coupler LLC | 67046-0422 | 67046-0422-03 |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | Coupler LLC | 67046-0423 | 67046-0423-03 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Coupler LLC | 67046-0858 | 67046-0858-03 |
| lisinopril | Lisinopril 10 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4509 | 70518-4509-00 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4397 | 70518-4397-00 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8562 | 68788-8562-0168788-8562-0368788-8562-06+1 more |
Other NDCs under ANDA 077321
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8254 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-232 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-1761 |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8255 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-232 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-5120 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Coupler LLC | 67046-0858 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | QPharma, Inc. | 42708-154 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-5121 |
| Lisinopril | Lisinopril 30 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2561 |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | QPharma, Inc. | 42708-165 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | American Health Packaging | 60687-325 |
| Lisinopril | Lisinopril 40 mg/1 | TabletOral | QPharma, Inc. | 42708-176 |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | American Health Packaging | 60687-333 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Major Pharmaceuticals | 0904-6797 |
| Lisinopril | Lisinopril 30 mg/1 | TabletOral | Northwind Health Company, LLC | 82868-009 |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | Major Pharmaceuticals | 0904-6799 |
| Lisinopril | Lisinopril 5 mg/1 | TabletOral | Proficient Rx LP | 71205-471 |
| Lisinopril | Lisinopril 20 mg/1 | TabletOral | Proficient Rx LP | 71205-180 |
| Lisinopril | Lisinopril 10 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-638 |
Showing 20 of 40.